Literature DB >> 26405591

Smoking-induced immune deviation contributes to progression of bladder and other cancers.

Jessica M Clement1, Fei Duan2, Pramod K Srivastava2.   

Abstract

We propose here that cigarette smoke (CS), in addition to its established genotoxic effects, elicits chronic albeit sub-clinical immune suppression, which is a major contributor to cancer progression. This hypothesis, presented here primarily in the context of bladder cancers (BCs), is applicable to other cancers, including those without a confirmed link to smoking.

Entities:  

Keywords:  CD8+ T cells; immune suppression; immune surveillance; tumor infiltrating lymphocytes

Year:  2015        PMID： 26405591      PMCID： PMC4570144          DOI： 10.1080/2162402X.2015.1019199

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  29 in total

Review 1.  Cigarette smoking and innate immunity.

Authors:  H Mehta; K Nazzal; R T Sadikot
Journal:  Inflamm Res       Date:  2008-11       Impact factor: 4.575

2.  Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer.

Authors:  T Morita; A Tokue; N Minato
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

Review 4.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

5.  Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer.

Authors:  Laura M Rogers; Alicia K Olivier; David K Meyerholz; Adam J Dupuy
Journal:  J Immunol       Date:  2013-03-08       Impact factor: 5.422

6.  Inhalation of tobacco smoke induces increased proliferation of urinary bladder epithelium and endothelium in female C57BL/6 mice.

Authors:  Takamasa Ohnishi; Lora L Arnold; Jun He; Nicole M Clark; Shin Kawasaki; Stephen I Rennard; Craig W Boyer; Samuel M Cohen
Journal:  Toxicology       Date:  2007-08-19       Impact factor: 4.221

7.  Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.

Authors:  J Carballido; M Alvarez-Mon; O J Solovera; L Menéndez-Ondina; A Durántez
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

8.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

9.  Invasive vulvar tumors in young women--a disease of the immunosuppressed?

Authors:  J Carter; J Carlson; J Fowler; E Hartenbach; L Adcock; L Carson; L B Twiggs
Journal:  Gynecol Oncol       Date:  1993-12       Impact factor: 5.482

Review 10.  Lung carcinogenesis by tobacco smoke.

Authors:  Stephen S Hecht
Journal:  Int J Cancer       Date:  2012-10-03       Impact factor: 7.396
View more
  1 in total

Review 1.  The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.

Authors:  Steven F Powell; Lexi Vu; William C Spanos; Dohun Pyeon
Journal:  Cancers (Basel)       Date:  2021-10-17       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.